eczema topic dermatitis
Conditions
Interventions
None listed
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years at time of study entry 2. Written Informed Consent. 3. Diagnosis of chronic atopic dermatitis for at least 1 year prior to enrollment 4. Use of licensed targeted immuno therapy within routine care
Exclusion criteria
Exclusion criteria: 1. Experiencing or history of other concomitant skin condition that would interfere with evaluations of the effect of medication on atopic dermatitis. 2. Patients with a tendency to develop hypertrophic scars
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Molecular stratification tools and *hard* molecular endpoints for disease control on the individual patient level. Aanalysis of tissue-derived signatures with *circulating signatures* detectable in liquid biopsies (bood and tissue liquids), employing state-of-the-art profiling technologies corresponding to multi-Omics datasets. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands
Outcome results
None listed